Counsel parents after an abnormal newborn bloodspot screen for X-linked adrenoleukodystrophy — OSCE

Communication task

The candidate is asked to counsel the parents of a screen-positive infant. The goal is to convey accurate information in plain language, to manage the parents' fear and their internet-driven worst-case assumptions, to explain what a screening test is and why it must be confirmed, and to lay out a clear, time-sensitive pathway — all while building trust and shared decision-making. [1] [2]

Key teaching points

What the screen means. The newborn bloodspot screen measures a fat in the blood called C26:0 lysophosphatidylcholine. A raised level is a flag, not a diagnosis: it tells us to look more closely, but it does not tell us whether the baby has the disease, how severe it might be, or whether he will ever become unwell. Many babies with a positive screen carry a mild change or a change of uncertain meaning, and some will never develop problems. The next step is to confirm, not to assume the worst. [1]

What X-linked adrenoleukodystrophy is, in plain language. It is an inherited condition in which a single transporter inside a small part of the cell does not work, so a particular kind of fat builds up. In some boys this fat injures the adrenal glands and the brain, but many boys with the gene change never develop the brain involvement. It is passed through the mother's side, which is why we will also talk about testing other family members in due course. [2]

The confirmatory pathway. The family will be seen by the metabolic team within days. We will arrange a blood test to confirm the very-long-chain fatty acid level, a genetic test to look at the ABCD1 gene, a blood test to check the baby's adrenal glands, and a brain scan to look at the white matter. None of these are urgent in the sense of an emergency today, but they are important and should not wait. [1] [2]

The surveillance plan. If the diagnosis is confirmed, the baby will be followed with regular brain scans and adrenal checks so that if the brain involvement ever begins, we find it early — early enough that a treatment such as a stem cell transplant can work. The point of screening is to find these boys before any symptom, and that is exactly where your baby is now: well, and watched. [1] [3]

Marking criteria

A strong candidate acknowledges the parents' fear before giving information, uses plain language without jargon, distinguishes clearly between a screen and a diagnosis, names the specific confirmatory tests and the timeframe, describes a surveillance plan that is reassuring without being dismissive, and checks the parents' understanding throughout. A weak candidate overwhelms the parents with technical detail, gives a premature prognosis, or fails to address the fear that drove them to read the worst-case material online. [2] [3]